Vera Therapeutics Inc’s filing revealed that its PRESIDENT AND CEO Fordyce Marshall unloaded Company’s shares for reported $1.06 million on Sep 25 ’24. In the deal valued at $46.05 per share,23,125 shares were sold. As a result of this transaction, Fordyce Marshall now holds 307,972 shares worth roughly $12.32 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MARSHALL FORDYCE bought 7,500 shares, generating $350,325 in total proceeds.
Before that, SEIDENBERG BETH C sold 13,823 shares. Vera Therapeutics Inc shares valued at $584,793 were divested by the Director at a price of $42.31 per share. As a result of the transaction, SEIDENBERG BETH C now holds 146,553 shares, worth roughly $5.86 million.
Oppenheimer initiated its Vera Therapeutics Inc [VERA] rating to an Outperform in a research note published on January 25, 2024; the price target was $26. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Raymond James began covering VERA with “an Outperform” recommendation on December 18, 2023. Jefferies revised its rating on November 10, 2023. It rated VERA as “a Buy” which previously was an “a Hold”.
Price Performance Review of VERA
On Monday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock fall -2.03% to $40.01. Over the last five days, the stock has lost -9.48%. Vera Therapeutics Inc shares have risen nearly 160.14% since the year began. Nevertheless, the stocks have risen 197.03% over the past one year. While a 52-week high of $50.78 was reached on 03/01/24, a 52-week low of $9.24 was recorded on 01/19/24. SMA at 50 days reached $39.09, while 200 days put it at $37.08.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 38.85, which if violated will result in even more drops to 37.69. On the upside, there is a resistance level at 42.30. A further resistance level may holdings at 44.59. The Relative Strength Index (RSI) on the 14-day chart is 46.69, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.78%. Stochastics %K at 24.95% indicates the stock is a holding.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2024-09-13, growing by 0.38 million shares to a total of 6.46 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 6.08 million shares. There was a rise of 5.84%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 16, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $27 price target.
